Back to Search Start Over

T-score as an Indicator of Fracture Risk on Therapy: Evidence From Romosozumab vs Alendronate Treatment in the ARCH Trial

Authors :
Cosman, F
Lewiecki, E. Michael
Ebeling, Peter R.
Hesse, E
Napoli, N
Crittenden, Daria B.
Rojeski, M
Yang, W
Libanati, C
Ferrari, S
Source :
Osteologie; February 2020, Vol. 29 Issue: 1
Publication Year :
2020

Details

Language :
English
ISSN :
10191291
Volume :
29
Issue :
1
Database :
Supplemental Index
Journal :
Osteologie
Publication Type :
Periodical
Accession number :
ejs53819603
Full Text :
https://doi.org/10.1055/s-0039-3402889